How China Became the Biotech Industry’s Back-Office

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.
By Published On: Gennaio 21, 2026Categories: DesignCommenti disabilitati su How China Became the Biotech Industry’s Back-Office

Share This Story, Choose Your Platform!

About the author : admin